Foley Todd bought Aktis Oncology ($AKTS) shares once on the open market in the last year, totaling 4.2 million dollars, with the latest purchase on January 12, 2026. This ranks him 197th among 4983 insiders for purchase value, above the average of 1.5 million dollars per buyer and about three transactions. He made no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Foley Todd | Not found | C | Series B Redeemable Convertible Preferred Stock | 2727273 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Foley Todd | Not found | C | Common Stock | 597391 | $0.00 | 597,391.0000 | 0 | 9999.99% | 0.00% |
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Foley Todd | Not found | C | Common Stock | 2688270 | $0.00 | 3,285,661.0000 | 0 | 450.00% | 0.00% |
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Foley Todd | Not found | C | Common Stock | 716872 | $0.00 | 4,002,533.0000 | 0 | 21.82% | 0.00% |
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Foley Todd | Not found | P | Common Stock | 232870 | $18.00 | 4,235,403.0000 | 0 | 5.82% | 0.00% |
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Foley Todd | Not found | C | Series Seed Redeemable Convertible Preferred Stock | 2272727 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Foley Todd | Not found | C | Series A Redeemable Convertible Preferred Stock | 10227273 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 8, 2023 | Repare Therapeutics Inc. | $RPTX | Foley Todd | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |